 | • レポートコード：QY2108PAL8916 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける白金抗がん剤の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、白金抗がん剤の種類別市場規模（シスプラチン、オキサリプラチン、カルボプラチン、その他）、用途別市場規模（結腸直腸がん、卵巣がん、肺がん、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の白金抗がん剤市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における白金抗がん剤の種類別市場規模（2016年-2027年）：シスプラチン、オキサリプラチン、カルボプラチン、その他 ・世界における白金抗がん剤の用途別市場規模（2016年-2027年）：結腸直腸がん、卵巣がん、肺がん、その他 ・白金抗がん剤の中国市場分析 - 白金抗がん剤の中国市場規模（2016年-2027年） - 中国における白金抗がん剤の主要プレイヤー別市場シェア - 中国における白金抗がん剤の種類別市場規模：シスプラチン、オキサリプラチン、カルボプラチン、その他 - 中国における白金抗がん剤の用途別市場規模：結腸直腸がん、卵巣がん、肺がん、その他 ・白金抗がん剤の北米市場（2016年-2027年） ・白金抗がん剤のヨーロッパ市場（2016年-2027年） ・白金抗がん剤のアジア太平洋市場（2016年-2027年） ・白金抗がん剤の中南米市場（2016年-2027年） ・白金抗がん剤の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Sanofi、Hengrui Medicine、ASK Pharma、Yi Bai Pharmaceutical、Qilu Pharmaceutical、Teva、Pfizer、Dr Reddy's Laboratories、Mylan、Sun Pharma、Novartis、Debiopharm、Accord Healthcare、SK Chemicals ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
Market Analysis and Insights: Global and China Platinum based Cancer Drug Market
This report focuses on global and China Platinum based Cancer Drug market.
In 2020, the global Platinum based Cancer Drug market size was US$ 1483.3 million and it is expected to reach US$ 1809.2 million by the end of 2027, with a CAGR of 2.7% during 2021-2027. In China the Platinum based Cancer Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Platinum based Cancer Drug Scope and Market Size
Platinum based Cancer Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Platinum based Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Platinum based Cancer Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others
Segment by Application
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy’s Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
1 Study Coverage
1.1 Platinum based Cancer Drug Product Introduction
1.2 Market by Type
1.2.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type
1.2.2 Cisplatin
1.2.3 Oxaliplatin
1.2.4 Carboplatin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Platinum based Cancer Drug Market Size Growth Rate by Application
1.3.2 Colorectal Cancer
1.3.3 Ovarian Cancer
1.3.4 Lung Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Platinum based Cancer Drug Market Size, Estimates and Forecasts
2.1.1 Global Platinum based Cancer Drug Revenue 2016-2027
2.1.2 Global Platinum based Cancer Drug Sales 2016-2027
2.2 Global Platinum based Cancer Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Platinum based Cancer Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Platinum based Cancer Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Platinum based Cancer Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Platinum based Cancer Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Platinum based Cancer Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Platinum based Cancer Drug Revenue Forecast by Region (2022-2027)
3 Global Platinum based Cancer Drug Competitor Landscape by Players
3.1 Global Top Platinum based Cancer Drug Manufacturers by Sales
3.1.1 Global Platinum based Cancer Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Platinum based Cancer Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Platinum based Cancer Drug Manufacturers by Revenue
3.2.1 Key Platinum based Cancer Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Platinum based Cancer Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Platinum based Cancer Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Platinum based Cancer Drug Revenue in 2020
3.2.6 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Platinum based Cancer Drug Price by Manufacturers
3.4 Global Platinum based Cancer Drug Manufacturing Base Distribution, Product Types
3.4.1 Platinum based Cancer Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Platinum based Cancer Drug Product Type
3.4.3 Date of International Manufacturers Enter into Platinum based Cancer Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Platinum based Cancer Drug Market Size by Type (2016-2021)
4.1.1 Global Platinum based Cancer Drug Sales by Type (2016-2021)
4.1.2 Global Platinum based Cancer Drug Revenue by Type (2016-2021)
4.1.3 Platinum based Cancer Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Platinum based Cancer Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Platinum based Cancer Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Platinum based Cancer Drug Revenue Forecast by Type (2022-2027)
4.2.3 Platinum based Cancer Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Platinum based Cancer Drug Market Size by Application (2016-2021)
5.1.1 Global Platinum based Cancer Drug Sales by Application (2016-2021)
5.1.2 Global Platinum based Cancer Drug Revenue by Application (2016-2021)
5.1.3 Platinum based Cancer Drug Price by Application (2016-2021)
5.2 Platinum based Cancer Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Platinum based Cancer Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Platinum based Cancer Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Platinum based Cancer Drug Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Platinum based Cancer Drug Market Size YoY Growth 2016-2027
6.1.1 China Platinum based Cancer Drug Sales YoY Growth 2016-2027
6.1.2 China Platinum based Cancer Drug Revenue YoY Growth 2016-2027
6.1.3 China Platinum based Cancer Drug Market Share in Global Market 2016-2027
6.2 China Platinum based Cancer Drug Market Size by Players (International and Local Players)
6.2.1 China Top Platinum based Cancer Drug Players by Sales (2016-2021)
6.2.2 China Top Platinum based Cancer Drug Players by Revenue (2016-2021)
6.3 China Platinum based Cancer Drug Historic Market Review by Type (2016-2021)
6.3.1 China Platinum based Cancer Drug Sales Market Share by Type (2016-2021)
6.3.2 China Platinum based Cancer Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Platinum based Cancer Drug Price by Type (2016-2021)
6.4 China Platinum based Cancer Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Platinum based Cancer Drug Sales Forecast by Type (2022-2027)
6.4.2 China Platinum based Cancer Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Platinum based Cancer Drug Price Forecast by Type (2022-2027)
6.5 China Platinum based Cancer Drug Historic Market Review by Application (2016-2021)
6.5.1 China Platinum based Cancer Drug Sales Market Share by Application (2016-2021)
6.5.2 China Platinum based Cancer Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Platinum based Cancer Drug Price by Application (2016-2021)
6.6 China Platinum based Cancer Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Platinum based Cancer Drug Sales Forecast by Application (2022-2027)
6.6.2 China Platinum based Cancer Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Platinum based Cancer Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Platinum based Cancer Drug Market Size YoY Growth 2016-2027
7.2 North America Platinum based Cancer Drug Market Facts & Figures by Country
7.2.1 North America Platinum based Cancer Drug Sales by Country (2016-2021)
7.2.2 North America Platinum based Cancer Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Platinum based Cancer Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Platinum based Cancer Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Platinum based Cancer Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Platinum based Cancer Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Platinum based Cancer Drug Market Size YoY Growth 2016-2027
9.2 Europe Platinum based Cancer Drug Market Facts & Figures by Country
9.2.1 Europe Platinum based Cancer Drug Sales by Country (2016-2021)
9.2.2 Europe Platinum based Cancer Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Platinum based Cancer Drug Market Size YoY Growth 2016-2027
10.2 Latin America Platinum based Cancer Drug Market Facts & Figures by Country
10.2.1 Latin America Platinum based Cancer Drug Sales by Country (2016-2021)
10.2.2 Latin America Platinum based Cancer Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Platinum based Cancer Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Platinum based Cancer Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Platinum based Cancer Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Platinum based Cancer Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Description and Business Overview
12.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Sanofi Platinum based Cancer Drug Products Offered
12.1.5 Sanofi Recent Development
12.2 Hengrui Medicine
12.2.1 Hengrui Medicine Corporation Information
12.2.2 Hengrui Medicine Description and Business Overview
12.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Hengrui Medicine Platinum based Cancer Drug Products Offered
12.2.5 Hengrui Medicine Recent Development
12.3 ASK Pharma
12.3.1 ASK Pharma Corporation Information
12.3.2 ASK Pharma Description and Business Overview
12.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 ASK Pharma Platinum based Cancer Drug Products Offered
12.3.5 ASK Pharma Recent Development
12.4 Yi Bai Pharmaceutical
12.4.1 Yi Bai Pharmaceutical Corporation Information
12.4.2 Yi Bai Pharmaceutical Description and Business Overview
12.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Products Offered
12.4.5 Yi Bai Pharmaceutical Recent Development
12.5 Qilu Pharmaceutical
12.5.1 Qilu Pharmaceutical Corporation Information
12.5.2 Qilu Pharmaceutical Description and Business Overview
12.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Products Offered
12.5.5 Qilu Pharmaceutical Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Description and Business Overview
12.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Platinum based Cancer Drug Products Offered
12.6.5 Teva Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Description and Business Overview
12.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Platinum based Cancer Drug Products Offered
12.7.5 Pfizer Recent Development
12.8 Dr Reddy’s Laboratories
12.8.1 Dr Reddy’s Laboratories Corporation Information
12.8.2 Dr Reddy’s Laboratories Description and Business Overview
12.8.3 Dr Reddy’s Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Dr Reddy’s Laboratories Platinum based Cancer Drug Products Offered
12.8.5 Dr Reddy’s Laboratories Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Description and Business Overview
12.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Platinum based Cancer Drug Products Offered
12.9.5 Mylan Recent Development
12.10 Sun Pharma
12.10.1 Sun Pharma Corporation Information
12.10.2 Sun Pharma Description and Business Overview
12.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sun Pharma Platinum based Cancer Drug Products Offered
12.10.5 Sun Pharma Recent Development
12.11 Sanofi
12.11.1 Sanofi Corporation Information
12.11.2 Sanofi Description and Business Overview
12.11.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Sanofi Platinum based Cancer Drug Products Offered
12.11.5 Sanofi Recent Development
12.12 Debiopharm
12.12.1 Debiopharm Corporation Information
12.12.2 Debiopharm Description and Business Overview
12.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Debiopharm Products Offered
12.12.5 Debiopharm Recent Development
12.13 Accord Healthcare
12.13.1 Accord Healthcare Corporation Information
12.13.2 Accord Healthcare Description and Business Overview
12.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Accord Healthcare Products Offered
12.13.5 Accord Healthcare Recent Development
12.14 SK Chemicals
12.14.1 SK Chemicals Corporation Information
12.14.2 SK Chemicals Description and Business Overview
12.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2016-2021)
12.14.4 SK Chemicals Products Offered
12.14.5 SK Chemicals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Platinum based Cancer Drug Industry Trends
13.2 Platinum based Cancer Drug Market Drivers
13.3 Platinum based Cancer Drug Market Challenges
13.4 Platinum based Cancer Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Platinum based Cancer Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Platinum based Cancer Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Cisplatin
Table 3. Major Manufacturers of Oxaliplatin
Table 4. Major Manufacturers of Carboplatin
Table 5. Major Manufacturers of Others
Table 6. Global Platinum based Cancer Drug Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Platinum based Cancer Drug Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Platinum based Cancer Drug Sales by Regions (2016-2021) & (K Units)
Table 9. Global Platinum based Cancer Drug Sales Market Share by Regions (2016-2021)
Table 10. Global Platinum based Cancer Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Platinum based Cancer Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Platinum based Cancer Drug Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Platinum based Cancer Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Platinum based Cancer Drug Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Platinum based Cancer Drug Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Platinum based Cancer Drug Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Platinum based Cancer Drug Manufacturers by Revenue (US$ Million) in 2020
Table 18. Platinum based Cancer Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Platinum based Cancer Drug Revenue Share by Manufacturers (2016-2021)
Table 20. Global Platinum based Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Platinum based Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2020)
Table 22. Key Manufacturers Platinum based Cancer Drug Price (2016-2021) (USD/Unit)
Table 23. Platinum based Cancer Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Platinum based Cancer Drug Product Type
Table 25. Date of International Manufacturers Enter into Platinum based Cancer Drug Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Platinum based Cancer Drug Sales by Type (2016-2021) (K Units)
Table 28. Global Platinum based Cancer Drug Sales Share by Type (2016-2021)
Table 29. Global Platinum based Cancer Drug Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Platinum based Cancer Drug Revenue Share by Type (2016-2021)
Table 31. Platinum based Cancer Drug Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global Platinum based Cancer Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Platinum based Cancer Drug Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Platinum based Cancer Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Platinum based Cancer Drug Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Platinum based Cancer Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Platinum based Cancer Drug Sales by Application (2016-2021) (K Units)
Table 38. Global Platinum based Cancer Drug Sales Share by Application (2016-2021)
Table 39. Global Platinum based Cancer Drug Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Platinum based Cancer Drug Revenue Share by Application (2016-2021)
Table 41. Platinum based Cancer Drug Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global Platinum based Cancer Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Platinum based Cancer Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Platinum based Cancer Drug Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Platinum based Cancer Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. China Platinum based Cancer Drug Sales (K Units) of Key Companies (2016-2021)
Table 48. China Platinum based Cancer Drug Sales Share by Company (2016-2021)
Table 49. China Platinum based Cancer Drug Revenue (US$ Million) by Company (2016-2021)
Table 50. China Platinum based Cancer Drug Revenue Share by Company (2016-2021)
Table 51. China Platinum based Cancer Drug Sales (K Units) by Type (2016-2021)
Table 52. China Platinum based Cancer Drug Sales Share by Type (2016-2021)
Table 53. China Platinum based Cancer Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Platinum based Cancer Drug Price (USD/Unit) by Type (2016-2021)
Table 55. China Platinum based Cancer Drug Sales (K Units) by Type (2022-2027)
Table 56. China Platinum based Cancer Drug Sales Share by Type (2022-2027)
Table 57. China Platinum based Cancer Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Platinum based Cancer Drug Revenue Share by Type (2022-2027)
Table 59. China Platinum based Cancer Drug Price (USD/Unit) by Type (2022-2027)
Table 60. China Platinum based Cancer Drug Sales (K Units) by Application (2016-2021)
Table 61. China Platinum based Cancer Drug Sales Share by Application (2016-2021)
Table 62. China Platinum based Cancer Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Platinum based Cancer Drug Price (USD/Unit) by Application (2016-2021)
Table 64. China Platinum based Cancer Drug Sales (K Units) by Application (2022-2027)
Table 65. China Platinum based Cancer Drug Sales Share by Application (2022-2027)
Table 66. China Platinum based Cancer Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Platinum based Cancer Drug Revenue Share by Application (2022-2027)
Table 68. China Platinum based Cancer Drug Price (USD/Unit) by Application (2022-2027)
Table 69. North America Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units)
Table 70. North America Platinum based Cancer Drug Sales Market Share by Country (2016-2021)
Table 71. North America Platinum based Cancer Drug Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Platinum based Cancer Drug Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Platinum based Cancer Drug Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Platinum based Cancer Drug Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Platinum based Cancer Drug Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Platinum based Cancer Drug Revenue Market Share by Region (2016-2021)
Table 77. Europe Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units)
Table 78. Europe Platinum based Cancer Drug Sales Market Share by Country (2016-2021)
Table 79. Europe Platinum based Cancer Drug Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Platinum based Cancer Drug Revenue Market Share by Country (2016-2021)
Table 81. Latin America Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Platinum based Cancer Drug Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Platinum based Cancer Drug Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Platinum based Cancer Drug Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Platinum based Cancer Drug Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Platinum based Cancer Drug Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Country (2016-2021)
Table 89. Sanofi Corporation Information
Table 90. Sanofi Description and Business Overview
Table 91. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. Sanofi Platinum based Cancer Drug Product
Table 93. Sanofi Recent Development
Table 94. Hengrui Medicine Corporation Information
Table 95. Hengrui Medicine Description and Business Overview
Table 96. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Hengrui Medicine Product
Table 98. Hengrui Medicine Recent Development
Table 99. ASK Pharma Corporation Information
Table 100. ASK Pharma Description and Business Overview
Table 101. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. ASK Pharma Product
Table 103. ASK Pharma Recent Development
Table 104. Yi Bai Pharmaceutical Corporation Information
Table 105. Yi Bai Pharmaceutical Description and Business Overview
Table 106. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Yi Bai Pharmaceutical Product
Table 108. Yi Bai Pharmaceutical Recent Development
Table 109. Qilu Pharmaceutical Corporation Information
Table 110. Qilu Pharmaceutical Description and Business Overview
Table 111. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Qilu Pharmaceutical Product
Table 113. Qilu Pharmaceutical Recent Development
Table 114. Teva Corporation Information
Table 115. Teva Description and Business Overview
Table 116. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. Teva Product
Table 118. Teva Recent Development
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Business Overview
Table 121. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Pfizer Product
Table 123. Pfizer Recent Development
Table 124. Dr Reddy's Laboratories Corporation Information
Table 125. Dr Reddy's Laboratories Description and Business Overview
Table 126. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Dr Reddy's Laboratories Product
Table 128. Dr Reddy's Laboratories Recent Development
Table 129. Mylan Corporation Information
Table 130. Mylan Description and Business Overview
Table 131. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. Mylan Product
Table 133. Mylan Recent Development
Table 134. Sun Pharma Corporation Information
Table 135. Sun Pharma Description and Business Overview
Table 136. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 137. Sun Pharma Product
Table 138. Sun Pharma Recent Development
Table 139. Novartis Corporation Information
Table 140. Novartis Description and Business Overview
Table 141. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 142. Novartis Product
Table 143. Novartis Recent Development
Table 144. Debiopharm Corporation Information
Table 145. Debiopharm Description and Business Overview
Table 146. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Debiopharm Product
Table 148. Debiopharm Recent Development
Table 149. Accord Healthcare Corporation Information
Table 150. Accord Healthcare Description and Business Overview
Table 151. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Accord Healthcare Product
Table 153. Accord Healthcare Recent Development
Table 154. SK Chemicals Corporation Information
Table 155. SK Chemicals Description and Business Overview
Table 156. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 157. SK Chemicals Product
Table 158. SK Chemicals Recent Development
Table 159. Platinum based Cancer Drug Market Trends
Table 160. Platinum based Cancer Drug Market Drivers
Table 161. Platinum based Cancer Drug Market Challenges
Table 162. Platinum based Cancer Drug Market Restraints
Table 163. Platinum based Cancer Drug Customers List
Table 164. Platinum based Cancer Drug Distributors List
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Platinum based Cancer Drug Product Picture
Figure 2. Global Platinum based Cancer Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Cisplatin Product Picture
Figure 4. Oxaliplatin Product Picture
Figure 5. Carboplatin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Platinum based Cancer Drug Sales Market Share by Application in 2020 & 2027
Figure 8. Colorectal Cancer
Figure 9. Ovarian Cancer
Figure 10. Lung Cancer
Figure 11. Others
Figure 12. Platinum based Cancer Drug Report Years Considered
Figure 13. Global Platinum based Cancer Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Platinum based Cancer Drug Market Size 2016-2027 (US$ Million)
Figure 15. Global Platinum based Cancer Drug Sales 2016-2027 (K Units)
Figure 16. Global Platinum based Cancer Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Platinum based Cancer Drug Sales Market Share by Region (2016-2021)
Figure 18. Global Platinum based Cancer Drug Sales Market Share by Region in 2020
Figure 19. Global Platinum based Cancer Drug Revenue Market Share by Region (2016-2021)
Figure 20. Global Platinum based Cancer Drug Revenue Market Share by Region in 2020
Figure 21. Global Platinum based Cancer Drug Sales Share by Manufacturer in 2020
Figure 22. The Top 10 and 5 Players Market Share by Platinum based Cancer Drug Revenue in 2020
Figure 23. Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 24. Global Platinum based Cancer Drug Sales Market Share by Type (2016-2021)
Figure 25. Global Platinum based Cancer Drug Sales Market Share by Type in 2020
Figure 26. Global Platinum based Cancer Drug Revenue Market Share by Type (2016-2021)
Figure 27. Global Platinum based Cancer Drug Revenue Market Share by Type in 2020
Figure 28. Global Platinum based Cancer Drug Sales Market Share by Application (2016-2021)
Figure 29. Global Platinum based Cancer Drug Sales Market Share by Application in 2020
Figure 30. Global Platinum based Cancer Drug Revenue Market Share by Application (2016-2021)
Figure 31. Global Platinum based Cancer Drug Revenue Market Share by Application in 2020
Figure 32. China Platinum based Cancer Drug Sales Growth Rate 2016-2027 (K Units)
Figure 33. China Platinum based Cancer Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 34. China Platinum based Cancer Drug Market Share in Global Market 2016-2027
Figure 35. China 5 and 10 Largest Platinum based Cancer Drug Players Market Share by Revenue in Platinum based Cancer Drug in 2020
Figure 36. China Platinum based Cancer Drug Revenue Share by Type (2016-2021)
Figure 37. China Platinum based Cancer Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 38. China Platinum based Cancer Drug Revenue Share by Application (2016-2021)
Figure 39. China Platinum based Cancer Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Platinum based Cancer Drug Sales Growth Rate 2016-2021 (K Units)
Figure 41. North America Platinum based Cancer Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 42. North America Platinum based Cancer Drug Sales Market Share by Country in 2020
Figure 43. North America Platinum based Cancer Drug Revenue Market Share by Country in 2020
Figure 44. U.S. Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 45. U.S. Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Canada Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 47. Canada Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Europe Platinum based Cancer Drug Sales Growth Rate 2016-2021 (K Units)
Figure 49. Europe Platinum based Cancer Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 50. Europe Platinum based Cancer Drug Sales Market Share by Country in 2020
Figure 51. Europe Platinum based Cancer Drug Revenue Market Share by Country in 2020
Figure 52. Germany Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 53. Germany Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. France Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 55. France Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. U.K. Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 57. U.K. Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Italy Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 59. Italy Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Russia Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 61. Russia Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Asia Pacific Platinum based Cancer Drug Sales Growth Rate 2016-2021 (K Units)
Figure 63. Asia Pacific Platinum based Cancer Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 64. Asia Pacific Platinum based Cancer Drug Sales Market Share by Region in 2020
Figure 65. Asia Pacific Platinum based Cancer Drug Revenue Market Share by Region in 2020
Figure 66. China Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 67. China Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. Japan Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 69. Japan Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. South Korea Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 71. South Korea Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. India Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 73. India Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Australia Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 75. Australia Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. China Taiwan Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 77. China Taiwan Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Indonesia Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 79. Indonesia Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Thailand Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 81. Thailand Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Malaysia Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 83. Malaysia Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Platinum based Cancer Drug Sales Growth Rate 2016-2021 (K Units)
Figure 85. Latin America Platinum based Cancer Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Platinum based Cancer Drug Sales Market Share by Country in 2020
Figure 87. Latin America Platinum based Cancer Drug Revenue Market Share by Country in 2020
Figure 88. Mexico Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 89. Mexico Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 91. Brazil Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 93. Argentina Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Platinum based Cancer Drug Sales Growth Rate 2016-2021 (K Units)
Figure 95. Middle East and Africa Platinum based Cancer Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Platinum based Cancer Drug Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Country in 2020
Figure 98. Turkey Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 99. Turkey Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 101. Saudi Arabia Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. UAE Platinum based Cancer Drug Sales Growth Rate (2016-2021) (K Units)
Figure 103. UAE Platinum based Cancer Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Platinum based Cancer Drug Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
ペプチドベース癌治療薬の世界市場 2020年 Market Overview The global Peptide Based Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Peptide Bas…- 転移性卵巣がん治療薬の世界市場 2020年 Market Overview The global Metastatic Ovarian Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic Ova…
- 卵巣がん診断技術の世界市場 2020年 Market Overview The global Ovarian Cancer Diagnostics Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ovari…
- 未分化甲状腺がん治療薬の世界市場 2020年 Market Overview The global Anaplastic Thyroid Cancer Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anaplastic Thy…
- 大腸がん分子診断の世界市場 2020年 Market Overview The global Colorectal Cancer Molecular Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Color…